Cargando…
Selection of Optimal Cell Lines for High-Content Phenotypic Screening
[Image: see text] High-content microscopy offers a scalable approach to screen against multiple targets in a single pass. Prior work has focused on methods to select “optimal” cellular readouts in microscopy screens. However, methods to select optimal cell line models have garnered much less attenti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127200/ https://www.ncbi.nlm.nih.gov/pubmed/36920184 http://dx.doi.org/10.1021/acschembio.2c00878 |
_version_ | 1785030413554548736 |
---|---|
author | Heinrich, Louise Kumbier, Karl Li, Li Altschuler, Steven J. Wu, Lani F. |
author_facet | Heinrich, Louise Kumbier, Karl Li, Li Altschuler, Steven J. Wu, Lani F. |
author_sort | Heinrich, Louise |
collection | PubMed |
description | [Image: see text] High-content microscopy offers a scalable approach to screen against multiple targets in a single pass. Prior work has focused on methods to select “optimal” cellular readouts in microscopy screens. However, methods to select optimal cell line models have garnered much less attention. Here, we provide a roadmap for how to select the cell line or lines that are best suited to identify bioactive compounds and their mechanism of action (MOA). We test our approach on compounds targeting cancer-relevant pathways, ranking cell lines in two tasks: detecting compound activity (“phenoactivity”) and grouping compounds with similar MOA by similar phenotype (“phenosimilarity”). Evaluating six cell lines across 3214 well-annotated compounds, we show that optimal cell line selection depends on both the task of interest (e.g., detecting phenoactivity vs inferring phenosimilarity) and distribution of MOAs within the compound library. Given a task of interest and a set of compounds, we provide a systematic framework for choosing optimal cell line(s). Our framework can be used to reduce the number of cell lines required to identify hits within a compound library and help accelerate the pace of early drug discovery. |
format | Online Article Text |
id | pubmed-10127200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-101272002023-04-26 Selection of Optimal Cell Lines for High-Content Phenotypic Screening Heinrich, Louise Kumbier, Karl Li, Li Altschuler, Steven J. Wu, Lani F. ACS Chem Biol [Image: see text] High-content microscopy offers a scalable approach to screen against multiple targets in a single pass. Prior work has focused on methods to select “optimal” cellular readouts in microscopy screens. However, methods to select optimal cell line models have garnered much less attention. Here, we provide a roadmap for how to select the cell line or lines that are best suited to identify bioactive compounds and their mechanism of action (MOA). We test our approach on compounds targeting cancer-relevant pathways, ranking cell lines in two tasks: detecting compound activity (“phenoactivity”) and grouping compounds with similar MOA by similar phenotype (“phenosimilarity”). Evaluating six cell lines across 3214 well-annotated compounds, we show that optimal cell line selection depends on both the task of interest (e.g., detecting phenoactivity vs inferring phenosimilarity) and distribution of MOAs within the compound library. Given a task of interest and a set of compounds, we provide a systematic framework for choosing optimal cell line(s). Our framework can be used to reduce the number of cell lines required to identify hits within a compound library and help accelerate the pace of early drug discovery. American Chemical Society 2023-03-15 /pmc/articles/PMC10127200/ /pubmed/36920184 http://dx.doi.org/10.1021/acschembio.2c00878 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Heinrich, Louise Kumbier, Karl Li, Li Altschuler, Steven J. Wu, Lani F. Selection of Optimal Cell Lines for High-Content Phenotypic Screening |
title | Selection of
Optimal Cell Lines for High-Content Phenotypic
Screening |
title_full | Selection of
Optimal Cell Lines for High-Content Phenotypic
Screening |
title_fullStr | Selection of
Optimal Cell Lines for High-Content Phenotypic
Screening |
title_full_unstemmed | Selection of
Optimal Cell Lines for High-Content Phenotypic
Screening |
title_short | Selection of
Optimal Cell Lines for High-Content Phenotypic
Screening |
title_sort | selection of
optimal cell lines for high-content phenotypic
screening |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127200/ https://www.ncbi.nlm.nih.gov/pubmed/36920184 http://dx.doi.org/10.1021/acschembio.2c00878 |
work_keys_str_mv | AT heinrichlouise selectionofoptimalcelllinesforhighcontentphenotypicscreening AT kumbierkarl selectionofoptimalcelllinesforhighcontentphenotypicscreening AT lili selectionofoptimalcelllinesforhighcontentphenotypicscreening AT altschulerstevenj selectionofoptimalcelllinesforhighcontentphenotypicscreening AT wulanif selectionofoptimalcelllinesforhighcontentphenotypicscreening |